The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance
Open accessAbstract
The incidence and prevalence of nontuberculous mycobacterial (NTM) infections have been increasing worldwide and lately led to an emerging public health problem. Among rapidly growing NTM, Mycobacterium abscessus is the most pathogenic and drug resistant opportunistic germ, responsible for disease manifestations ranging from “curable” skin infections to only “manageable” pulmonary disease. Challenges in M. abscessus treatment stem from the bacteria’s high-level innate resistance and comprise long, costly and non-standardized administration of antimicrobial agents, poor treatment outcomes often related to adverse effects and drug toxicities, and high relapse rates. Drug resistance in M. abscessus is conferred by an assortment of mechanisms. Clinically acquired drug resistance is normally conferred by mutations in the target genes. Intrinsic resistance is attributed to low permeability of M. abscessus cell envelope as well as to (multi)drug export systems. However, expression of numerous enzymes by M. abscessus, which can modify either the drug-target or the drug itself, is the key factor for the pathogen’s phenomenal resistance to most classes of antibiotics used for treatment of other moderate to severe infectious diseases, like macrolides, aminoglycosides, rifamycins, β-lactams and tetracyclines. In 2009, when M. abscessus genome sequence became available, several research groups worldwide started studying M. abscessus antibiotic resistance mechanisms. At first, lack of tools for M. abscessus genetic manipulation severely delayed research endeavors. Nevertheless, the last 5 years, significant progress has been made towards the development of conditional expression and homologous recombination systems for M. abscessus. As a result of recent research efforts, an erythromycin ribosome methyltransferase, two aminoglycoside acetyltransferases, an aminoglycoside phosphotransferase, a rifamycin ADP-ribosyltransferase, a β-lactamase and a monooxygenase were identified to frame the complex and multifaceted intrinsic resistome of M. abscessus, which clearly contributes to complications in treatment of this highly resistant pathogen. Better knowledge of the underlying mechanisms of drug resistance in M. abscessus could improve selection of more effective chemotherapeutic regimen and promote development of novel antimicrobials which can overwhelm the existing resistance mechanisms. This article reviews the currently elucidated molecular mechanisms of antibiotic resistance in M. abscessus, with a focus on its drug-target-modifying and drug-modifying enzymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Call of the wild: antibiotic resistance genes in natural environments
Allen, H. K., Donato, J., Wang, H. H., Cloud-Hansen, K. A., Davies, J., & Handelsman, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2312 · Cited by 2,361
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Brown-Elliott, B. A., & Wallace, R. J. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.716-746.2002 · Cited by 909
Hoefsloot, W., van Ingen, J., Andrejak, C., Ängeby, K., Bauriaud, R., Bemer, P., Beylis, N., Boeree, M. J., Cacho, J., Chihota, V., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00149212 · Cited by 838
Mycobacterium abscessus: a new antibiotic nightmare
Nessar, R., Cambau, E., Reyrat, J. M., Murray, A., & Gicquel, B. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr578 · Cited by 799
Nash, K. A., Brown-Elliott, B. A., & Wallace, R. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-08 · Cited by 638
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
Bryant, J. M., Grogono, D. M., Rodriguez-Rincon, D., Everall, I., Brown, K. P., Moreno, P., Verma, D., Hill, E., Drijkoningen, J., Gilligan, P., et al. (2016) · Science · doi:10.1126/science.aaf8156 · Cited by 587
Mycobacterium abscessus Complex Infections in Humans
Lee, M.-R., Sheng, W.-H., Hung, C.-C., Yu, C.-J., Lee, L.-N., & Hsueh, P.-R. (2015) · Emerging Infectious Diseases · doi:10.3201/2109.141634 · Cited by 568
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Next-generation approaches to understand and combat the antibiotic resistome
Crofts, T. S., Gasparrini, A. J., & Dantas, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.28 · Cited by 535
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Hugonnet, J.-E., Tremblay, L. W., Boshoff, H. I., Barry, C. E., & Blanchard, J. S. (2009) · Science · doi:10.1126/science.1167498 · Cited by 494
Jarand, J., Levin, A., Zhang, L., Huitt, G., Mitchell, J. D., & Daley, C. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq237 · Cited by 429
Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus
Ripoll, F., Pasek, S., Schenowitz, C., Dossat, C., Barbe, V., Rottman, M., Macheras, E., Heym, B., Herrmann, J.-L., Daffé, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005660 · Cited by 388
TetX Is a Flavin-dependent Monooxygenase Conferring Resistance to Tetracycline Antibiotics
Yang, W., Moore, I. F., Koteva, K. P., Bareich, D. C., Hughes, D. W., & Wright, G. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409573200 · Cited by 364
Howard, S. T., Rhoades, E., Recht, J., Pang, X., Alsup, A., Kolter, R., Lyons, C. R., & Byrd, T. F. (2006) · Microbiology · doi:10.1099/mic.0.28625-0 · Cited by 359
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Update on pulmonary disease due to non-tuberculous mycobacteria
Stout, J. E., Koh, W.-J., & Yew, W. W. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.03.006 · Cited by 355
Shin, D.-M., Jeon, B.-Y., Lee, H.-M., Jin, H. S., Yuk, J.-M., Song, C.-H., Lee, S.-H., Lee, Z.-W., Cho, S.-N., Kim, J.-M., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001230 · Cited by 338
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V., & Cambau, E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00861-10 · Cited by 333
Zaunbrecher, M. A., Sikes, R. D., Metchock, B., Shinnick, T. M., & Posey, J. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907925106 · Cited by 330
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Self-citationNTM drug discovery: status, gaps and the way forward
Wu, M.-L., Aziz, D. B., Dartois, V., & Dick, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.04.001 · Cited by 276
Genome-Scale Identification of Resistance Functions in Pseudomonas aeruginosa Using Tn-seq
Gallagher, L. A., Shendure, J., & Manoil, C. (2011) · mBio · doi:10.1128/mbio.00315-10 · Cited by 253
Haworth, C. S., Banks, J., Capstick, T., Fisher, A. J., Gorsuch, T., Laurenson, I. F., Leitch, A., Loebinger, M. R., Milburn, H. J., Nightingale, M., et al. (2017) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2017-000242 · Cited by 253
Prammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
Self-citationTortoli, E., Kohl, T. A., Brown-Elliott, B. A., Trovato, A., Leão, S. C., Garcia, M. J., Vasireddy, S., Turenne, C. Y., Griffith, D. E., Philley, J. V., et al. (2016) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.001376 · Cited by 241
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives
Ryu, Y. J., Koh, W.-J., & Daley, C. L. (2016) · Tuberculosis and Respiratory Diseases · doi:10.4046/trd.2016.79.2.74 · Cited by 239
The design and analysis of transposon insertion sequencing experiments
Chao, M. C., Abel, S., Davis, B. M., & Waldor, M. K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.7 · Cited by 217
Sanguinetti, M., Ardito, F., Fiscarelli, E., La Sorda, M., D'Argenio, P., Ricciotti, G., & Fadda, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.816-819.2001 · Cited by 210
Kim, H.-Y., Kim, B. J., Kook, Y., Yun, Y.-J., Shin, J. H., Kim, B.-J., & Kook, Y.-H. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00221.x · Cited by 209
Stanley, R. E., Blaha, G., Grodzicki, R. L., Strickler, M. D., & Steitz, T. A. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1755 · Cited by 207
Kim, K. H., An, D. R., Song, J., Yoon, J. Y., Kim, H. S., Yoon, H. J., Im, H. N., Kim, J., Kim, D. J., Lee, S. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120251109 · Cited by 203
A diverse intrinsic antibiotic resistome from a cave bacterium
Pawlowski, A. C., Wang, W., Koteva, K., Barton, H. A., McArthur, A. G., & Wright, G. D. (2016) · Nature Communications · doi:10.1038/ncomms13803 · Cited by 199
Choi, G.-E., Shin, S. J., Won, C.-J., Min, K.-N., Oh, T., Hahn, M.-Y., Lee, K., Lee, S. H., Daley, C. L., Kim, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2005oc · Cited by 194
Wallace, R. J., Dukart, G., Brown-Elliott, B. A., Griffith, D. E., Scerpella, E. G., & Marshall, B. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku062 · Cited by 188
Brown-Elliott, B. A., Vasireddy, S., Vasireddy, R., Iakhiaeva, E., Howard, S. T., Nash, K., Parodi, N., Strong, A., Gee, M., Smith, T., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02950-14 · Cited by 182
Role of embB in natural and acquired resistance to ethambutol in mycobacteria
Alcaide, F., Pfyffer, G. E., & Telenti, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2270 · Cited by 172
Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance
Linkevicius, M., Sandegren, L., & Andersson, D. I. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02465-15 · Cited by 165
β-Lactamase inhibition by avibactam in Mycobacterium abscessus
Dubée, V., Bernut, A., Cortes, M., Lesne, T., Dorchene, D., Lefebvre, A.-L., Hugonnet, J.-E., Gutmann, L., Mainardi, J.-L., Herrmann, J.-L., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku510 · Cited by 164
Genetic Basis of Persister Tolerance to Aminoglycosides in Escherichia coli
Shan, Y., Lazinski, D. W., Rowe, S. E., Camilli, A., & Lewis, K. (2015) · mBio · doi:10.1128/mbio.00078-15 · Cited by 155
Characterization of broad-spectrum Mycobacterium abscessus class A -lactamase
Soroka, D., Dubée, V., Soulier-Escrihuela, O., Cuinet, G., Hugonnet, J., Gutmann, L., Mainardi, J., & Arthur, M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt410 · Cited by 155
Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes
Park, J., Gasparrini, A. J., Reck, M. R., Symister, C. T., Elliott, J. L., Vogel, J. P., Wencewicz, T. A., Dantas, G. A., & Tolia, N. H. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2376 · Cited by 148
Rominski, A., Roditscheff, A., Selchow, P., Böttger, E. C., & Sander, P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw466 · Cited by 143
Self-citationRifabutin Is Active against Mycobacterium abscessus Complex
Aziz, D. B., Low, J. L., Wu, M.-L., Gengenbacher, M., Teo, J. W. P., Dartois, V. A., & Dick, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00155-17 · Cited by 137
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Dupont, C., Viljoen, A. J., Dubar, F., Blaise, M., Bernut, A., Pawlik, A., Bouchier, C., Brosch, R., Guérardel, Y., Lelièvre, J., et al. (2016) · Molecular Microbiology · doi:10.1111/mmi.13406 · Cited by 129
Dupont, C., Viljoen, A. J., Thomas, S. S., Roquet, F., Herrmann, J., Pethe, K., & Kremer, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01225-17 · Cited by 126
Maurer, F. P., Rüegger, V. L., Ritter, C., Bloemberg, G. V., & Böttger, E. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks279 · Cited by 124
Quan, S., Venter, H., & Dabbs, E. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2456 · Cited by 123
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
Yang, B., Jhun, B. W., Moon, S. M., Lee, H. J., Park, H. Y., Jeon, K., Kim, D. H., Kim, S., Shin, S. J., Daley, C. L., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02052-16 · Cited by 122
Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase
Volkers, G., Palm, G. J., Weiss, M. S., Wright, G. D., & Hinrichs, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.012 · Cited by 116
Hurst-Hess, K., Rudra, P., & Ghosh, P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01347-17 · Cited by 115
Choo, S. W., Wee, W. Y., Ngeow, Y. F., Mitchell, W., Tan, J. L., Wong, G. J., Zhao, Y., & Xiao, J. (2014) · Scientific Reports · doi:10.1038/srep04061 · Cited by 97
Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis
Wivagg, C. N., Bhattacharyya, R. P., & Hung, D. T. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.94 · Cited by 96
Rudra, P., Hurst-Hess, K. R., Lappierre, P., & Ghosh, P. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00119-18 · Cited by 93
Cambau, E., Viveiros, M., Machado, D., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku438 · Cited by 91
Rominski, A., Selchow, P., Becker, K., Brülle, J. K., Molin, M. D., & Sander, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx125 · Cited by 84
Self-citationHalloum, I., Viljoen, A. J., Khanna, V., Craig, D., Bouchier, C., Brosch, R., Coxon, G. D., & Kremer, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02509-16 · Cited by 83
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex
Lavollay, M., Dubée, V., Heym, B., Herrmann, J., Gaillard, J., Gutmann, L., Arthur, M., & Mainardi, J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12405 · Cited by 82
The evolution of substrate discrimination in macrolide antibiotic resistance enzymes
Pawlowski, A. C., Stogios, P. J., Koteva, K. K., Skarina, T., Evdokimova, E., Savchenko, A. V., & Wright, G. D. (2018) · Nature Communications · doi:10.1038/s41467-017-02680-0 · Cited by 80
Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity
Franz, N. D., Belardinelli, J. M., Kaminski, M. A., Dunn, L. C., de Moura, V. C. N., Blaha, M. A., Truong, D. D., Li, W., Jackson, M., & North, E. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.015 · Cited by 77
Kozikowski, A. P., Onajole, O. K., Stec, J., Dupont, C., Viljoen, A. J., Richard, M., Chaira, T., Lun, S., Bishai, W. R., Raj, V. S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00582 · Cited by 77
Rox, a Rifamycin Resistance Enzyme with an Unprecedented Mechanism of Action
Koteva, K. K., Cox, G., Kelso, J., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.01.009 · Cited by 74
Kaushik, A., Gupta, C., Fisher, S., Story‐Roller, E., Galanis, C., Parrish, N. M., & Lamichhane, G. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0234 · Cited by 72
Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus
Kim, T. S., Choe, J. H., Kim, Y. J., Yang, C., Kwon, H., Jeong, J., Kim, G., Park, D. E., Jo, E., Cho, Y. L., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02752-16 · Cited by 71
Burian, J., Ramón‐García, S., Howes, C. G., & Thompson, C. J. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.90 · Cited by 70
Run, E. L., Arthur, M., & Mainardi, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01915-18 · Cited by 69
Rajagopal, M., Martin, M. J., Santiago, M., Lee, W., Kos, V. N., Meredith, T., Gilmore, M. S., & Walker, S. (2016) · mBio · doi:10.1128/mbio.00950-16 · Cited by 66
An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs
Kinch, M. S., & Patridge, E. V. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.012 · Cited by 59
Pryjma, M., Burian, J., Kuchinski, K. S., & Thompson, C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01353-17 · Cited by 58
Rominski, A., Schulthess, B., Müller, D. M., Keller, P. M., & Sander, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx284 · Cited by 51
Self-citationMolecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus
Molin, M. D., Gut, M., Rominski, A., Haldimann, K., Becker, K., & Sander, P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01427-17 · Cited by 51
Self-citationChen, W., Green, K. D., Tsodikov, O. V., & Garneau‐Tsodikova, S. (2012) · Biochemistry · doi:10.1021/bi3004473 · Cited by 49
Run, E. L., Arthur, M., & Mainardi, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00623-18 · Cited by 39
Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
Mukherjee, D., Wu, M.-L., Teo, J. W. P., & Dick, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01298-17 · Cited by 37
Novel Streptomycin Resistance Gene from Mycobacterium fortuitum
Ramón‐García, S., Otal, I., Martı́n, C., Gómez-Lus, R., & Aínsa, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00223-06 · Cited by 35
Maurer, F. P., Bruderer, V. L., Castelberg, C., Ritter, C., Shcherbakov, D., Bloemberg, G. V., & Böttger, E. C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku550 · Cited by 28
Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
Aziz, D. B., Teo, J. W. P., Dartois, V. A., & Dick, T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00932 · Cited by 27
Binding of the Highly Toxic Tetracycline Derivative, Anhydrotetracycline, to Bovine Serum Albumin
Burgos, I., Fernández, R. A., Celej, M. S., Rossi, L. I., Fidelio, G. D., & Dassie, S. A. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1301 · Cited by 19
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
Johansen, M. D., Herrmann, J.-L., & Kremer, L. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0331-1 · Cited by 822
Recent updates on drug resistance in Mycobacterium tuberculosis
Singh, R., Dwivedi, S. P., Gaharwar, U. S., Meena, R., Rajamani, P., & Prasad, T. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14478 · Cited by 337
A macroevolution-inspired approach to reveal novel antibiotic resistance mechanisms
Subtil, F. T., Machado, T. F., Douglas, H., Kirkpatrick, J. M., Skehel, M., Garza-Garcia, A., & de Carvalho, L. P. S. (2026) · eLife · doi:10.7554/elife.101940 · Cited by 1
Metadata
- Authors
- Luthra, S., Rominski, A., & Sander, P.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-12
- Volume
- 9
- Pages
- 2179-2179
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2889161855
- Cited by
- 260
- References
- 83
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.